Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $2.30 $3.38 Friday, 10th May 2024 CLLS stock ended at $3.06. This is 5.56% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 9.00% from a day low at $3.00 to a day high of $3.27.
90 days $2.30 $3.38
52 weeks $0.96 $3.77

Historical Cellectis S.A. prices

Date Open High Low Close Volume
Aug 11, 2016 $27.42 $27.49 $26.96 $27.02 32 800
Aug 10, 2016 $27.79 $28.32 $27.39 $27.58 99 000
Aug 09, 2016 $27.75 $27.91 $26.90 $27.91 104 900
Aug 08, 2016 $28.37 $28.37 $27.70 $27.76 45 400
Aug 05, 2016 $27.72 $28.69 $27.71 $28.35 90 000
Aug 04, 2016 $27.63 $27.98 $27.53 $27.69 77 700
Aug 03, 2016 $26.83 $27.65 $26.76 $27.50 59 300
Aug 02, 2016 $27.10 $27.31 $26.62 $27.20 64 600
Aug 01, 2016 $25.95 $27.46 $25.95 $27.10 88 500
Jul 29, 2016 $26.01 $26.37 $25.63 $26.37 61 900
Jul 28, 2016 $26.35 $26.35 $25.77 $26.10 76 400
Jul 27, 2016 $25.76 $26.03 $25.43 $26.01 83 100
Jul 26, 2016 $25.50 $25.74 $25.25 $25.39 112 500
Jul 25, 2016 $25.43 $25.43 $24.96 $25.25 61 700
Jul 22, 2016 $25.09 $25.37 $24.82 $25.21 54 900
Jul 21, 2016 $25.37 $25.66 $25.05 $25.14 54 200
Jul 20, 2016 $25.20 $25.65 $25.11 $25.38 44 400
Jul 19, 2016 $25.71 $25.77 $25.10 $25.25 51 500
Jul 18, 2016 $26.02 $26.02 $25.71 $25.88 40 600
Jul 15, 2016 $25.77 $26.15 $25.69 $25.91 49 600
Jul 14, 2016 $26.15 $26.24 $25.44 $25.56 95 700
Jul 13, 2016 $26.86 $27.00 $25.75 $25.85 177 600
Jul 12, 2016 $25.89 $25.93 $25.41 $25.41 34 900
Jul 11, 2016 $26.09 $26.21 $25.51 $25.75 115 400
Jul 08, 2016 $26.25 $26.25 $23.95 $25.15 577 400
Click to get the best stock tips daily for free!

About Cellectis S.A.

Cellectis S.A. Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALL... CLLS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT